Finzati - Logo
DOCS logo

Doximity, Inc.

DOCSMedical - Healthcare Information Services
$0.00
0.00 (0.00%)
EarningsLatest report: Jun 30, 2026
HIGHLY FAVORABLE PROFILEExcellentConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Strong business quality with supportive growth and cash-flow evidence. Valuation still matters, but the historical ratio profile is favorable.
Market Cap
$3.86B
Growth
32.9%
Cash Flow
5/5
Trend
Stable
Evidence
Stable or improving margins · 30.4%Positive revenue growth · 13.2%Positive free cash flow · 1.7Consistent free cash flow · 5/5Manageable debt level · 0.01
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 7, 2026, 12:47 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$0.00
Change0.00%
Market Cap$3.86B
52W Range17.15 - 76.51
Beta1.29
Gross Margin89.09%
Oper. Margin33.33%
Profit Margin30.40%
Debt/Eq0.01
Current Ratio6.09
Quick Ratio6.09
Revenue 5Y32.87%

Investment DNA

How strong this company looks for long-term investors

82
out of 100
Business Quality
Margins, moat, returns
85/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
61/100
Why this score
Stable or improving margins · 30.4%Positive revenue growth · 13.2%Positive free cash flow · 1.7Consistent free cash flow · 5/5Manageable debt level · 0.01Healthy liquidity · 6.09

Analyst view

Analyst sentiment and price target

Analyst sentiment
No vote count available
Bullish
0
Hold
0
Bearish
0
Price Target
2026-08-07
Low
$18.00
Mean
$25.29
Median
$24.50
High
$42.00

Company Overview

IPO: 6/24/2021
Industry: Medical - Healthcare Information Services
P/B i: 4.58
Debt / Equity i: 0.01
Operating Margin: 33.33%
Net Margin: 30.40%
ROE i: -
ROIC: -

Financial Health

Score15 / 20
Debt / Equity: 0.01
Current Ratio: 6.09
Quick Ratio: 6.09
Status: Good

Insider Transactions

Recent executive and insider activity

ZATZ STEVEN L
Transaction: 07/22/2026
BUY
Change
+150,000
Price
$20.49
Filing
07/24/2026
Type
BUY
Tangney Jeffrey
Transaction: 07/22/2026
BUY
Change
+2,480,000
Price
$28.02
Filing
07/24/2026
Type
BUY
Sitaram Siddharth
Transaction: 07/15/2026
SELL
Change
-4,800
Price
Not reported
Filing
07/20/2026
Type
SELL